OTC : EVOTF
$0 (0.0%)
| Source | Headline |
|---|---|
|
Evotec Q2 Earnings Call Highlights
Evotec NASDAQ: EVO reported preliminary unaudited results for the second quarter and first half of 2026 and lowered its full-year outlook, citing delayed strategic partnership revenue, slower conversion of commercial activity into revenue and longer timelines for new partnership agreements. marketbeat.com - 2026-07-14 09:03:38 |